Cited 5966 times in
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.